Thus, there is strong signaling crosstalk between mast cells and the S1P axis, and targeting the S1P axis to regulate mast cells is also crucial evidence that S1P treatment improves inflammation in psoriasis. This evidence concerns the gene MBTPS1 and psoriasis.